Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21019359 | 0.93 | MAPT (0.31) | ALKWEE1 | |
| SCHEMBL21020163 | 0.92 | ALK (0.32) | ALK | |
| SCHEMBL21019177 | 0.92 | CDC14B (0.31) | — | |
| SCHEMBL25878051 | 0.91 | ALK (0.31) | ALK | |
| SCHEMBL24539792 | 0.90 | ALK (0.30) | ALK | |
| SCHEMBL21019897 | 0.90 | CDC14B (0.32) | ALK | |
| SCHEMBL21019617 | 0.90 | MEN1 (0.33) | ALK | |
| SCHEMBL27012020 | 0.90 | ALK (0.30) | ALK | |
| SCHEMBL24539712 | 0.89 | ALK (0.31) | ALK | |
| SCHEMBL25878162 | 0.89 | MAPT (0.32) | ALK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10995098-B2 | Heterocyclic compound and organic light emitting device comprising the same | LG CHEM, LTD. (KR) | 2021-05-04 | — | — | US | disclosed |
| US-20190152985-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2019-05-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190152985-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | CRY1, CYP1A1, CYP1B1 | ALK 2361/4885WEE1 556/4885 |
| US-10995098-B2 | Heterocyclic compound and organic light emitting device comprising the same | CRY1, CYP1A1, CYP1B1 | ALK 2361/4885WEE1 556/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.